It is also possible that elevated CRP levels lead to fibrinolytic resistance and endothelial dysfunction by affecting fibrin clot structure, highlighting its prothrombogenic effects on injured vessel walls [84,85]. The gene discussed is CRP; the disease is endothelial dysfunction.